Antifungal activity of magnolol and honokiol
- 368 Downloads
Two neolignan compounds, magnolol (5,5′-diallyl-2,2′-dihydroxybiphenyl,1) and honokiol (5,5′-diallyl-2,4′-dihydroxybiphenyl,2), were isolated from the stem bark ofMagnolia obovata and evaluated for antifungal activity against various human pathogenic fungi. Compound1 and2 showed significant inhibitory activities againstTrichophyton mentagrophytes, Microsporium gypseum, Epidermophyton floccosum, Aspergillus niger, Cryptococcus neoformans, andCandida albicans with minimum inhibitory concentrations (MIC) in a range of 25–100 μg/ml. Therefore, compound1 and2 could be used as lead compounds for the development of novel antifungal agents.
Key wordsMagnolol Honokiol Human pathogenic fungi Magnolia obovata Magnoliaceae
Unable to display preview. Download preview PDF.
- Huang, K. C.,The Pharmacology of Chinese Herb’s. CRE Press, Ann Arbor, p. 173, 1993.Google Scholar
- Moore, G. S. and Jaciow, D. W.,Mycology for the clinical laboratory. Reston Publishing, Virginia, pp. 262–266 (1979).Google Scholar
- Namba, T., Tsunezuka, M., Bae, K. H. and Hattori, M., Studies on dental caries prevention by traditional Chinese medicines (part I), Screening of crude drugs for antibacterial action againstStreptococcus mutans.Shoyaku Zasshi, 35, 295–302 (1981).Google Scholar
- Ormsby, O. S. and Montgomery, M.,Disease of the skin. Lea & Fibiger, Philadelphia, p. 1128, 1954.Google Scholar
- Yahara, S., Nishiyori, T., Kohda, A., Nohara, T. and Nishioka I., Isolation and characterization of phenolic compounds from Magnoliae Cortex produced in China.Chem. Pharm. Bull., 39, 2024–2036 (1991).Google Scholar
- Yamaguchi, H., Antifungal agents-recent trends in development and progress in research of action mechanism.Jap. J. Clinic. Med., 49, 2176–2185 (1990).Google Scholar